Actively Recruiting
Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation
Led by King Chulalongkorn Memorial Hospital · Updated on 2024-01-17
180
Participants Needed
1
Research Sites
544 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.
CONDITIONS
Official Title
Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Deceased donor kidney transplantation at KCMH
- Informed consent is accepted
You will not qualify if you...
- Known allergy to furosemide
- Surgical complication of allograft
- Urgently needed for dialysis due to refractory hypervolemia, uremic symptoms, or hyperkalemia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
King Chulalongkorn Memorial Hospital
Bangkok, Thailand, 10330
Actively Recruiting
Research Team
S
Suwasin udomkarnjananun, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here